CentoNIPT® - Expertise you can trust
Illumina VeriSeq™ NIPT Solution*
CENTOGENE offers non-invasive prenatal testing that provides a fast and accurate screen for the most common prenatal chromosomal abnormalities.
CentoNIPT® is performed on a single maternal blood sample and combines the latest NGS technology with the highest quality medical reporting. It provides unparalleled accuracy and detection compared to other non-invasive testing methods – ultrasonography or nuchal translucency testing.
CentoNIPT® has the lowest test failure rate among all NIPT technologies on the market.
What does CentoNIPT® screen for?
- Down syndrome (Trisomy 21)
- Edwards syndrome (Trisomy 18)
- Patau syndrome (Trisomy 13)
The test also detects abnormalities of the sex chromosomes:
- Turner syndrome (Monosomy X)
- Klinefelter syndrome (XXY)
- Jacobs syndrome (XYY)
- Triple X syndrome (XXX)
CentoNIPT® is based on Verifi Prenatal Test & VeriSeq™ NIPT solution and offers the lowest number of unnecessary invasive testing
Your experts in non-invasive prenatal diagnostics
The CENTOGENE advantage
We offer a comprehensive package starting with NIPT for most common chromosome aneuploidies to prenatal whole exome / whole genome sequencing. After birth, we offer biomarker testing and our whole genetic test portfolio including specialized genetic analysis for critically ill newborns on ICU.
High sensitivity & specificity
CentoNIPT® combines next generation sequencing with integrated measurement of fetal fraction, even at fetal fraction < 4%. This concludes in the lowest technical failure rate and unnecessary invasive testing as follow-up of NIPT tests available.
Fast & accurate results
Our optimized workflows provide a full clinical diagnostic report within five business days from high-quality, validated results.
Notation: *Sample Preparation and analysis software are CE-IVD marked
Noninvasive prenatal testing (NIPT) based on cell-free DNA analysis from maternal blood is a screening test; it is not diagnostic. Test results must not be used as the sole basis for diagnosis. Further confirmatory testing is necessary prior to making any irreversible pregnancy decision.